Browsing Tag
RNA medicine
3 posts
Analysts weigh Bristol Myers Squibb’s $1.5bn Orbital Therapeutics deal as a bold but risky pivot
Bristol Myers Squibb’s $1.5 billion acquisition of Orbital Therapeutics aims to advance in vivo CAR T for autoimmune diseases and strengthen its RNA platform.
$35 million boost for Rona Therapeutics: A new era in RNA medicine begins!
Rona Therapeutics, a clinical-stage company leading the way in nucleic acid drug research and development, has successfully completed…
Orna Therapeutics acquires ReNAgade Therapeutics, appoints new CEO to lead RNA therapeutics innovation
Orna Therapeutics, a pioneer in the field of circular RNA therapeutics, has officially announced its acquisition of ReNAgade…